論文 - 杉本　芳一

A novel yeast cell-based screening identifies flavone as a tankyrase inhibitor.

Yashiroda Y, Okamoto R, Hatsugai K, Takemoto Y, Goshima N, Saito T, Hamamoto M, Sugimoto Y, Osada H, Seimiya H, Yoshida M*.

Biochem Biophys Res Commun 394(3)   569-573 2010年03月

研究論文（学術雑誌）, 共著, 査読有り

Breast cancer resistance protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.

Usuda J*, Tsunoda Y, Ichinose S, Ishizumi T, Ohtani K, Maehara S, Ono S, Tsutsui H, Ohira T, Okunaka T, Furukawa K, Sugimoto Y, Kato H, Ikeda N.

Lung Cancer 67   198-204 2010年02月

研究論文（学術雑誌）, 共著, 査読有り

Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export.

Katayama R, Koike S, Sato S, Sugimoto Y, Tsuruo T, Fujita N*.

Cancer Sci 100   2060-2068 2009年11月

研究論文（学術雑誌）, 共著, 査読有り

Environmental contamination due to preparation of cyclophosphamide and exposure of pharmacists to it.

Hama T*, Aoyama T, Shirai T, Higuchi S, Yokokawa T, Sugimoto Y.

Jpn J Pharm Health Care Sci 35(10)   693-700 2009年09月

研究論文（学術雑誌）, 共著, 査読有り

Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib.

Noguchi K, Kawahara H, Kaji A, Katayama K, Mitsuhashi J, Sugimoto Y*.

Cancer Science 100   1701-1707 2009年09月

研究論文（学術雑誌）, 共著, 査読有り

Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.

Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, Sugimoto Y, Tsuruo T, Seimiya H*.

Cancer Sci 100   1556-1562 2009年08月

研究論文（学術雑誌）, 共著, 査読有り

CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.

Takeshita A*, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R.

Leukemia 23   1329-136 2009年07月

研究論文（学術雑誌）, 共著, 査読有り

CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukemia and lymphoma.

Takeshita A*, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Shigeno K, Nakamura S, Tobita T, Maekawa M, Ohnishi K, Sugimoto Y, Kiyoi H, Naoe T, Ohno R.

Br J Haematol 146   34-43 2009年06月

研究論文（学術雑誌）, 共著, 査読有り

Pharmacological interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling.

Katayama K, Shibata K, Mitsuhashi J, Noguchi K, Sugimoto Y.

Anticancer Reserch 29 （ 4 ） 1059-1065 2009年04月

研究論文（学術雑誌）, 共著, 査読有り

Identification of cytochrome P450s required for fumitoremorgin biosynthesis in Aspergillus fumigatus.

Kato, N, Suzuki H, Takagi H, Asami Y, Kakeya H, Uramoto M, Usui T, Takahashi S, Sugimoto Y, Osada H*.

Chembiochem 10   920-928 2009年03月

研究論文（学術雑誌）, 共著, 査読有り

Identification of cytochrome P450s required for fumitremorgin biosynthesis in Aspergillus fumigatus.

Kato, N, Suzuki H, Takagi H, Asami Y, Kakeya H, Uramoto M, Usui T, Takahashi S, Sugimoto Y, Osada H.

Chembiochem: a European journal of chemical biology 10 （ 5 ） 920-928 2009年03月

研究論文（学術雑誌）, 単著, 査読有り

Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.

'Mashima T, Sato S, Sugimoto Y, Tsuruo T, Seimiya, H*.'

Oncogene 28 （ 1 ） 9-19 2009年01月

研究論文（学術雑誌）, 共著, 査読有り

Functions of breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.

'Noguchi K, Katayama K, Mitsuhashi J, Sugimoto Y*.'

Advanced Drug Delivery Reviews （/Elsevier）  61   26-33 2009年01月

研究論文（学術雑誌）, 共著, 査読有り

Pharmacological Interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling.

Katayama K, Shibata K, Mitsuhashi J, Noguchi K, Sugimoto Y*.

Anticancer Research 29   1059-1065 2009年01月

研究論文（学術雑誌）, 共著, 査読有り

CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukemia and lymphoma.

Takeshita A, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Shigeno K, Nakamura S, Tobita T, Maekawa M, Ohnishi K, Sugimoto Y, Kiyoi H, Naoe T, Ohno R.

British journal of haematology 146   34-43 2009年

研究論文（学術雑誌）, 共著, 査読有り

CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.

Takeshita A, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R.

Leukemia 2009年

研究論文（学術雑誌）, 単著, 査読有り

Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.

Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, Sugimoto Y, Tsuruo T, Seimiya H.

Cancer Science 2009年

研究論文（学術雑誌）, 共著, 査読有り

Breast cancer resistance protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.

Usuda J, Tsunoda Y, Ichinose S, Ishizumi T, Ohtani K, Maehara S, Ono S, Tsutsui H, Ohira T, Okunaka T, Furukawa K, Sugimoto Y, Kato H, Ikeda N.

Lung Cancer 2009年

研究論文（学術雑誌）, 共著, 査読有り

Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib.

>

Cancer Science 2009年

研究論文（学術雑誌）, 共著, 査読有り

標的タンパク質・標的酵素の遺伝子多型と薬剤感受性.

杉本芳一.

腫瘍内科 （/科学評論社）  2(2)   136-144 2008年04月

研究論文（学術雑誌）, 単著, 査読有り